Adlai Nortye Group Balance Sheet
NASDAQ: ANLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Adlai Nortye Group financial position
At the end of fiscal 2024, Adlai Nortye Group reported total assets of $71.3 million, down 45.3% from a year earlier against total liabilities of $45.8 million. Shareholders' equity stood at $25.5 million, or 35.8% of assets. The company held $60.9 million in cash and equivalents against $26.3 million of debt, a net cash position of $34.6 million.
The current ratio (current assets divided by current liabilities) was 1.41, meaning short-term assets cover obligations due within a year. Debt-to-equity was 1.03.
Summary generated from market data by MetaCap's automated system. Methodology
Adlai Nortye Group balance sheet (annual)
| Fiscal year (USD) | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 |
|---|---|---|---|---|
| Cash & Equivalents | 60.90M | 91.49M | 42.76M | 64.13M |
| Total Current Assets | 64.06M | 101.19M | 66.30M | — |
| Property, Plant & Equipment | 1.74M | 2.65M | 3.71M | 3.65M |
| Intangible Assets | 40.00K | 63.00K | 89.00K | — |
| Total Assets | 71.27M | 130.19M | 72.59M | — |
| Short-Term Debt | 26.33M | 30.36M | 4.31M | — |
| Total Current Liabilities | 45.36M | 49.67M | 312.65M | — |
| Total Liabilities | 45.78M | 55.14M | 313.89M | — |
| Shareholders' Equity | 25.48M | 75.05M | -241.29M | -185.43M |
| Retained Earnings | -429.32M | -377.45M | -268.22M | — |
| Total Debt | 26.33M | 30.36M | 4.31M | — |
| Net Cash (Debt) | 34.57M | 61.13M | 38.45M | 64.13M |
| Shares Outstanding | — | — | 40.44M | — |
This table shows 4 annual periods of Adlai Nortye Group's balance sheet, from FY 2024 back to FY 2021, across 13 line items including cash & equivalents, total current assets, property, plant & equipment. Values in USD; B = billions, M = millions. Fiscal periods follow ANL's reporting calendar. What is a balance sheet?